The plan to replace Janet Woodcock’s substantial presence at the US Food and Drug Administration is beginning to take shape.
FDA Commissioner Robert Califf on 29 November announced that agency Chief Scientist Namandjé Bumpus would become principal deputy commissioner upon Woodcock’s retirement early next year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?